Q1 2022 Financial Results (Nasdaq: MRVI) May 5, 2022 LifeSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time-to-time make, ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39725 Maravai LifeSciences Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organizat ...

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR Commission file number 001-39725 Maravai LifeSciences Holdings, Inc. (Exact name of registrant as specified in its charter) | Delaware | 8731 | 85-2786970 | | --- | --- | --- | | (State o ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2021 Earnings Conference Call February 23, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Chief Executive Officer Kevin Herde - Executive Vice President and Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Yuko Oku - Morgan Stanley Paul Knight - KeyBanc Capital Markets Matt Larew - William Blair Catherine Schulte - Baird Michael Ryskin - Bank of America Merrill Lynch John Sourbeer ...

Q4 2021 Financial Results (Nasdaq: MRVI) February 23, 2022 LifeSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward Looking Statements and Use of Non-GAAP Financial Measures This presentation contains, and our officers and representatives may from time-to-time ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-39725 Maravai LifeSciences Holdings, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organ ...

Investor Presentation (Nasdaq: MRVI) November 2021 Sciences Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make, "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Investors are cautioned that statements in this presentation which are not strictly historical statements constitute forward-looking statements, includin ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q3 2021 Results Conference Call November 10, 2021 5:00 PM ET Company Participants Debra Hart - Senior Director, IR Carl Hull - CEO Kevin Herde - EVP, CFO Conference Call Participants Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Dan Arias - Stifel John Sourbeer - UBS Paul Knight - KeyBanc Matt Larew - William Blair Michael Ryskin - Bank of America Catherine Schulte - Baird Operator Good day, and thank you for standing by. Welcome to the Q3 2021 Ma ...

Q2 2021 Financial Results (Nasdaq: MRVI) August 10, 2021 eSciences Today's Agenda Welcome Deb Hart, Head of Investor Relations 01 Financial Results & Guidance Kevin Herde, Chief Financial Officer 02 Business Highlights & Update Carl Hull, Chief Executive Officer 03 04 Q&A Session Carl Hull, Chief Executive Officer Kevin Herde, Chief Financial Officer 2 Forward looking statements and use of non-GAAP financial measures This presentation contains, and our officers and representatives may from time-to-time make ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2021 Earnings Conference Call August 10, 2021 5:00 PM ET Company Participants Deb Hart - IR Carl Hull - Chairman and CEO Kevin Herde - CFO Conference Call Participants Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Dan Arias - Stifel Matt Larew - William Blair Michael Ryskin - Bank of America Operator Ladies and gentlemen thank you for standing by and welcome to the Maravai Lifesciences Second quarter 2021 earnings conference call. At this time ...